WHO Chief Tedros Says Mpox Vaccines Could Be Ready For Emergency Use Listing Within Two Weeks; Some Mpox Vaccines Expected To Arrive In Congo In The Next Few Days
Portfolio Pulse from Benzinga Newsdesk
The WHO Chief, Tedros, announced that Mpox vaccines could be ready for emergency use listing within two weeks, with some vaccines expected to arrive in Congo soon.
August 30, 2024 | 1:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Emergent BioSolutions (EBS) may be involved in the production or distribution of Mpox vaccines, which are expected to be ready for emergency use listing soon.
EBS is known for its involvement in vaccine production. The news of Mpox vaccines being ready for emergency use listing could positively impact EBS if they are involved in the production or distribution.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
GeoVax Labs (GOVX) might be impacted by the news of Mpox vaccines nearing emergency use listing, as they are involved in vaccine development.
GOVX is involved in vaccine development, and the news of Mpox vaccines being ready for emergency use listing could positively impact their stock if they are part of the supply chain.
CONFIDENCE 75
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
Moderna (MRNA) could be affected by the news of Mpox vaccines nearing emergency use listing, given their role in vaccine development.
MRNA is a key player in vaccine development. The announcement of Mpox vaccines being ready for emergency use listing could have a positive impact if they are involved.
CONFIDENCE 70
IMPORTANCE 40
RELEVANCE 50